These hs-cTn assays can detect very low concentrations of cardiac troponin T (cTnT) and troponin I (cTnI), allowing for more rapid diagnosis and risk stratification of patients with suspected acute coronary syndromes (ACS) [4]. This evidence concerns the gene TNNT2 and acute coronary syndrome.